Smith & Nephew (SNN) Invested Capital (2013 - 2025)
Smith & Nephew (SNN) posted quarterly Invested Capital of $15.0 million for Q4 2025, down 82.14% year-on-year from $84.0 million in Q4 2024, and down 82.14% on a QoQ basis from $84.0 million in Q4 2024.
Smith & Nephew (SNN) Invested Capital (2013 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Invested Capital for 13 consecutive years, with $15.0 million the latest figure, recorded in Q4 2025.
- Quarterly Invested Capital fell 82.14% year-over-year to $15.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $99.0 million (down 90.85% YoY) and the FY2025 annual result came in at $15.0 million, down 82.14% from the prior year.
- Invested Capital eased to $15.0 million in Q4 2025 per SNN's latest filing, from $84.0 million in the prior quarter.
- Over the last five years, Invested Capital for SNN reached as high as $1.2 billion in Q4 2021 and fell as low as $4.0 million in Q4 2023.
- A 5-year average of $464.6 million and a median of $84.0 million in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2023 — Invested Capital plunged 99.6% — and 2024, when it soared 2000.0%.
- Year by year, Invested Capital stood at $1.2 billion in 2021, then fell by 18.92% to $994.0 million in 2022, then tumbled by 99.6% to $4.0 million in 2023, then surged by 2000.0% to $84.0 million in 2024, then slumped by 82.14% to $15.0 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $15.0 million, $84.0 million, and $4.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.41 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 499.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 1.41 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 7.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 15.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 118.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 84.00 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 994.00 Mn |
| Dec 31, 2021 | 1.23 Bn |
| Dec 31, 2020 | 2.55 Bn |
| Dec 31, 2019 | 118.00 Mn |
| Dec 31, 2018 | 855.00 Mn |
| Jun 30, 2018 | -369.00 Mn |
| Dec 31, 2017 | 2.54 Bn |
| Dec 31, 2016 | 62.00 Mn |
| Dec 31, 2015 | 46.00 Mn |
| Jun 30, 2015 | 413.00 Mn |
| Dec 31, 2014 | 540.00 Mn |
| Mar 31, 2014 | 27.00 Mn |
| Dec 31, 2013 | 366.00 Mn |